Annette Hanson, MD, Ron Pies, MD, and Mark Komrad, MD
Authors respond to “How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis?” by arguing that patients’ motives for accessing death with dignity laws should be thoroughly explored and that temporarily limiting patient autonomy can promote well-being at the end of life.
AMA J Ethics. 2018;20(11):E1107-1109. doi:
10.1001/amajethics.2018.1107.
Alexander Craig, MPhil and Elizabeth Dzeng, MD, PhD, MPH
Responding to “Added Points of Concern about Caring for Dying Patients,” authors argue that physicians’ refusal to prescribe lethal drugs in accordance with states’ death with dignity laws could damage patient-physician relationships and harm patients.
AMA J Ethics. 2018;20(11):E1110-1112. doi:
10.1001/amajethics.2018.1110.
Elder self-neglect can be assessed with the Elder Self-Neglect Assessment (ESNA) and addressed by physicians’ partnering with patients to achieve common goals.
AMA J Ethics. 2017;19(10):1047-1050. doi:
10.1001/journalofethics.2017.19.10.corr2-1710.
Jessica Pierce, PhD, Marc Bekoff, PhD, Hope Ferdowsian, MD, MPH, Barbara J. King, PhD, and L. Syd M. Johnson, PhD
Our letter objects to the inclusion, in the April issue, of "Answers to Patient, Student, and Clinician Questions About How Animals Are Slaughtered and Used for Food," by Temple Grandin.
AMA J Ethics. 2023;25(6):E461-463. doi:
10.1001/amajethics.2023.461.
Clara C. Hildebrandt, MD and Jonathan M. Marron, MD, MPH
Gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies that could limit research participation by minority group members. These concerns can be addressed through public education, transparency, and stakeholder partnerships.
AMA J Ethics. 2018;20(9):E826-833. doi:
10.1001/amajethics.2018.826.
Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.